Skip to content

The effect of ultrasound-guided continuous supra-inguinal fascia iliaca compartment block and anterior quadratus lumborum block on postoperative recovery quality after hip fracture: a randomized controlled trial

The effect of ultrasound-guided continuous supra-inguinal fascia iliaca compartment block and anterior quadratus lumborum block on postoperative recovery quality after hip fracture: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037857
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-09-04
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative analgesia

Interventions

S-FICB group:continous supra-inguinal fascia iliaca compartment block
A-QLB group:continous anterior quadratus lumborum block

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with age >= 65 years old; 2. Patients with hip fracture confirmed by imaging examination; 3. Patients who plan to receive surgery (reduction and fixation or artificial joint replacement) under axial or general anesthesia; 4. Patients who agreed to receive regional nerve block or patient-controlled intravenous analgesia as perioperative analgesia measures; 5. Patients who agreed to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in the study; 2. Patients with BMI > 30kg / m2 or body weight IV grade; 4. Patients with other fractures or multiple injuries; 5. Patients with contraindications for deep nerve block, including but not limited to the following conditions: severe abnormal coagulation function (INR > 1.7, APTT over normal value for 4 seconds, platelet count < 80 x 10^9 / L), trauma or infection at the puncture site, and withdrawal time of new oral anticoagulants (dabigatran, apixaban, rivaroxaban, etc.) was less than 5 days; 6. Patients with chronic opioid dependence and long-term use of various types of analgesics (more than 3 months), such as patients with long-term joint pain; 7. Patients who are unable to communicate due to delirium, dementia, central and / or peripheral nervous system diseases, language disorders or other end-stage diseases; 8. Allergy to local anesthetics and other drugs used in the present study; 9. Other circumstances that the surgeon or investigator deems inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
recovery quality at 24 hours after surgery;

Secondary

MeasureTime frame
daily NRS pain scores at rest before surgery;NRS pain score at rest 1 hour after intervention;NRS pain score at movement on the set of positon changing when receiving axis anesthesia;NRS pain scores both at rest and with movement at 6, 24, 48, 72 hours after surgery;the rate of complication in hospital;the length of stay in hospital;the recovery qualilty on the day of dischargeday of;the Barthel index on the day of discharge;the modified Harris / Oxford hip score on the day of discharge;the Barthel index 3 months after surgery;the modified Harris /Oxford hip score 3 months after surgery;

Countries

China

Contacts

Public ContactXue Li

Peking University First Hospital

3999165@163.com+86 188 1052 7114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026